Endocrine Therapy for Endometrial Carcinoma: Current Evidence, Resistance Mechanisms, and Biomarker-Driven Patient Selection

The treatment landscape for endometrial carcinoma (EC) is undergoing a paradigm shift from traditional histopathological dualism to precision medicine grounded in the Cancer Genome Atlas (TCGA) molecular classification. The “No Specific Molecular Profile” (NSMP) subgroup, the largest molecular cohor...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Taro Yamanaka, Hiroshi Yoshida, Tatsunori Shimoi, Kazuki Sudo, Kan Yonemori
Formato:	Artigo
Idioma:	Inglês
Publicado em:	MDPI AG 2026-02-01
coleção:	Current Oncology
Assuntos:	endometrial cancer estrogen receptor progesterone receptor endocrine therapy progestin selective estrogen receptor degraders
Acesso em linha:	https://www.mdpi.com/1718-7729/33/2/124
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!